tiprankstipranks
Ra Medical Systems Inc (RMED)
NYSE MKT:RMED
Holding RMED?
Track your performance easily

Ra Medical Systems (RMED) Stock Price & Analysis

257 Followers

RMED Stock Chart & Stats


Risk Analysis

Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy

Website Traffic

Sorry, No Data Available
There is no website visitor data available for this stock.
---

RMED FAQ

What was Ra Medical Systems Inc’s price range in the past 12 months?
Currently, no data Available
What is Ra Medical Systems Inc’s market cap?
Currently, no data Available
When is Ra Medical Systems Inc’s upcoming earnings report date?
Ra Medical Systems Inc’s upcoming earnings report date is Nov 13, 2023 which is 395 days ago.
    How were Ra Medical Systems Inc’s earnings last quarter?
    Currently, no data Available
    Is Ra Medical Systems Inc overvalued?
    According to Wall Street analysts Ra Medical Systems Inc’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
      Does Ra Medical Systems Inc pay dividends?
      Ra Medical Systems Inc does not currently pay dividends.
      What is Ra Medical Systems Inc’s EPS estimate?
      Ra Medical Systems Inc’s EPS estimate for its next earnings report is not yet available.
      How many shares outstanding does Ra Medical Systems Inc have?
      Currently, no data Available
      What happened to Ra Medical Systems Inc’s price movement after its last earnings report?
      Currently, no data Available
      Which hedge fund is a major shareholder of Ra Medical Systems Inc?
      Among the largest hedge funds holding Ra Medical Systems Inc’s share is Royce & Associates LLC. It holds Ra Medical Systems Inc’s shares valued at N/A.
        ---

        Company Description

        Ra Medical Systems Inc

        Ra Medical Systems, Inc. engages in the design, development, and commercialization of excimer lasers for the treatment of dermatologic and cardiovascular diseases. Its product, Pharos, is used for the treatment of difficult-to-treat, chronic diseases including psoriasis and vitiligo. It operates through the Dermatology and Vascular business segments. The company was founded by Dean Irwin and Melissa Burstein in 2002 and is headquartered in Carlsbad, CA.
        ---
        Similar Stocks
        Company
        Price & Change
        Follow
        Aethlon Medical
        Avinger
        Bellerophon
        Capricor Therapeutics
        Popular Stocks
        ---
        What am I Missing?
        Make informed decisions based on Top Analysts' activity
        Know what industry insiders are buying
        Get actionable alerts from top Wall Street Analysts
        Find out before anyone else which stock is going to shoot up
        Get powerful stock screeners & detailed portfolio analysis